Targovax ASA Corporate Analyst Meeting Transcript
Thank you for attending the European Biotech Investor Day hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. My name is Nick Colangelo. I'm an analyst here at Solebury Trout.
Before I introduce the next speaker, I would like to remind you to please feel free to submit your questions throughout the presentation via the web platform. If the company does not have time to answer them during the presentation, they will follow-up individually.
And with that said, it is my pleasure to introduce the next speaker, Dr. Magnus Jäderberg, Chief Medical Officer of Targovax. Magnus, please go ahead.
¤ -
Thank you very much, Nick, and welcome to my talk. So Targovax is a Norwegian biotech company focusing on immuno-oncology products. And I have the pleasure today to talk to you about what we're up to. And my talk will fall into introductory part, mesothelioma and melanoma, which are our sponsored
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |